Skip to main content
Grant Details

Grant Number: 5R03CA272955-02 Interpret this number
Primary Investigator: Lupo, Philip
Organization: Baylor College Of Medicine
Project Title: Deep Phenotyping Children with Congenital Anomalies and Cancer Enrolled in Project:everychild
Fiscal Year: 2023


ABSTRACT One of the strongest risk factors for cancer in children and adolescents is being born with a congenital anomaly— this is true both for chromosomal abnormalities (e.g., Down syndrome) and non-chromosomal birth defects (e.g., non-syndromic congenital heart defects), as validated in our registry linkage study of over 10 million live births. A vital next step in this work is to assemble sufficiently large cohorts of families and children with congenital anomalies and cancer that include: 1) comprehensive phenotypic and clinical information, which can be used to ascertain syndromic characteristics, endophenotypes, and treatment outcomes; and 2) well-annotated biological samples, which can be used for wide-ranging molecular assessments. Without these cohorts and these data, it is difficult to translate findings from registry linkage studies into novel insights concerning disrupted development and cancer predisposition. Furthermore, providing a platform for the integration of these data will increase the power for detecting the pathways underlying congenital anomalies and cancer. Two important resources for addressing these gaps are: 1) Project:EveryChild (PEC); and 2) the Gabriella Miller Kids First Pediatric Data Resource Center (KF-DRC). PEC is the Children’s Oncology Group (COG) registry, eligibility screening, biology, and outcome study (APEC14B1) that has been open since 2015 and currently includes >25,000 children. The DRC is the platform for the Kids First program in terms of aggregation of curated genomic and phenotypic data from structural birth defects and childhood cancer cohorts, as well as a central portal where these data and analysis tools are accessible to the research community. The objective of this application is to deeply characterize the phenotypes of children with congenital anomalies and cancer enrolled in COG PEC and integrate these data in the KF-DRC. Our hypothesis is that the processes and informatic framework we develop will strengthen future Kids First datasets and their impact by providing an implementation template for obtaining curated phenotypic data from PEC to combine with genomic data being generated in COG as part of Kids First and the Childhood Cancer Data Initiative (CCDI). We are uniquely poised to lead this effort with deep experience in both PEC and the DRC. To meet our objective, we propose the following aims: 1) Collect extensive phenotypic and clinical data from children with congenital anomalies and cancer enrolled in Project:EveryChild; and 2) Integrate phenotypic and clinical data from Project:EveryChild into the Gabriella Miller Kids First Pediatric Data Resource Center. This study will generate a robust resource for Kids First by providing deep phenotypic data on children with congenital anomalies and cancer, as well as serving as a scalable template for obtaining and curating phenotypic data for cohorts of children in COG undergoing comprehensive molecular profiling as part of Kids First and the CCDI. Finally, this work may ultimately inform novel strategies for cancer screening, counseling, and treatment for at-risk children.


Role of non-chromosomal birth defects on the risk of developing childhood Hodgkin lymphoma: A Children's Oncology Group study.
Authors: Peckham-Gregory E.C. , Boff L.M. , Schraw J.M. , Spector L.G. , Linabery A.M. , Erhardt E.B. , Ribeiro K.B. , Allen C.E. , Scheurer M.E. , Lupo P.J. .
Source: Pediatric blood & cancer, 2024 Mar; 71(3), p. e30822.
EPub date: 2023-12-25.
PMID: 38146016
Related Citations

Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15 000 leukemia cases and 46 000 controls from the Childhood Cancer and Leukemia International Consortium.
Authors: Lupo P.J. , Chambers T.M. , Mueller B.A. , Clavel J. , Dockerty J.D. , Doody D.R. , Erdmann F. , Ezzat S. , Filippini T. , Hansen J. , et al. .
Source: International journal of cancer, 2024-02-01; 154(3), p. 434-447.
EPub date: 2023-09-11.
PMID: 37694915
Related Citations

Associations between birth defects with neural crest cell origins and pediatric embryonal tumors.
Authors: Wong E.C. , Lupo P.J. , Desrosiers T.A. , Nichols H.B. , Smith S.M. , Poole C. , Canfield M. , Shumate C. , Chambers T.M. , Schraw J.M. , et al. .
Source: Cancer, 2023-11-15; 129(22), p. 3595-3602.
EPub date: 2023-07-11.
PMID: 37432072
Related Citations

Children's Oncology Group's 2023 blueprint for research: Epidemiology.
Authors: Lupo P.J. , Marcotte E.L. , Scheurer M.E. , Poynter J.N. , Spector L.G. , COG Epidemiology Committee .
Source: Pediatric blood & cancer, 2023 Sep; 70 Suppl 6(Suppl 6), p. e30566.
EPub date: 2023-07-14.
PMID: 37449937
Related Citations

Identification of USP9X as a leukemia susceptibility gene.
Authors: Sisoudiya S.D. , Mishra P. , Li H. , Schraw J.M. , Scheurer M.E. , Salvi S. , Doddapaneni H. , Muzny D. , Mitchell D. , Taylor O. , et al. .
Source: Blood advances, 2023-08-22; 7(16), p. 4563-4575.
PMID: 37289514
Related Citations

Back to Top